SG Americas Securities’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-63,181
Closed -$8.22M 3759
2025
Q4
$8.22M Buy
63,181
+57,090
+937% +$7.84M 0.01% 860
2025
Q3
$656K Buy
6,091
+3,846
+171% +$419K ﹤0.01% 1873
2025
Q2
$207K Sell
2,245
-8,206
-79% -$644K ﹤0.01% 2244
2025
Q1
$926K Buy
10,451
+1,716
+20% +$149K ﹤0.01% 1236
2024
Q4
$671K Buy
8,735
+4,068
+87% +$284K ﹤0.01% 1103
2024
Q3
$198K Buy
+4,667
New +$158K ﹤0.01% 2505
2023
Q2
Sell
-3,255
Closed -$39K 3243
2023
Q1
$39K Buy
3,255
+641
+25% +$8.54K ﹤0.01% 3094
2022
Q4
$23K Sell
2,614
-416
-14% -$9.17K ﹤0.01% 2919
2022
Q3
$88K Buy
3,030
+1,020
+51% +$46.7K ﹤0.01% 2887
2022
Q2
$84K Buy
+2,010
New +$136K ﹤0.01% 3179
2022
Q1
Sell
-591
Closed -$87K 3493
2021
Q4
$87K Sell
591
-211
-26% -$47.1K ﹤0.01% 3113
2021
Q3
$201K Sell
802
-521
-39% -$179K ﹤0.01% 3236
2021
Q2
$612K Buy
1,323
+116
+10% +$49.8K ﹤0.01% 1855
2021
Q1
$593K Buy
+1,207
New +$628K ﹤0.01% 1893

Other funds holding WGS

SG Americas Securities's WGS Position: Q1 2026 in Review

SG Americas Securities sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 63,181 shares — an estimated $8.22M sold.

SG Americas Securities first reported a position in WGS in Q1 2021 and held it in 14 quarters. The position peaked at $8.22M in Q4 2025. 241 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • SG Americas Securities reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 63,181 GeneDx Holdings shares in Q1 2026, an estimated $8.22M.
  • SG Americas Securities first reported a position in GeneDx Holdings in Q1 2021 and held it in 14 quarters.
  • SG Americas Securities's GeneDx Holdings position peaked at $8.22M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.